Kyowa Kirin Co., Ltd. (TYO: 4151)
Japan
· Delayed Price · Currency is JPY
2,567.50
-42.00 (-1.61%)
Nov 13, 2024, 3:45 PM JST
Kyowa Kirin Revenue
Kyowa Kirin had revenue of 129.82B JPY in the quarter ending September 30, 2024, with 21.51% growth. This brings the company's revenue in the last twelve months to 498.98B, up 18.62% year-over-year. In the year 2023, Kyowa Kirin had annual revenue of 442.23B with 11.01% growth.
Revenue (ttm)
498.98B
Revenue Growth
+18.62%
P/S Ratio
2.74
Revenue / Employee
83.52M
Employees
5,974
Market Cap
1,308.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 442.23B | 43.86B | 11.01% |
Dec 31, 2022 | 398.37B | 46.13B | 13.09% |
Dec 31, 2021 | 352.25B | 33.89B | 10.65% |
Dec 31, 2020 | 318.35B | 12.53B | 4.10% |
Dec 31, 2019 | 305.82B | -40.71B | -11.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKyowa Kirin News
- 15 days ago - Kyowa Kirin 9M GAAP EPS of Yen 105.19, revenue of Yen 362.8B - Seeking Alpha
- 15 days ago - Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company - Business Wire
- 5 weeks ago - Kyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024 - Business Wire
- 7 weeks ago - Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis - PRNewsWire
- 2 months ago - Kyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual Meeting - PRNewsWire
- 2 months ago - New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphataemia (XLH) - Financial Post
- 3 months ago - Kyowa Kirin to end distribution of Fareston (toremefine) in the United States - PRNewsWire
- 3 months ago - Kyowa Kirin International and NewBridge Pharmaceuticals Enter Into Agreement to Improve Access to Medicines for Rare Disease Patients Across Middle East and North Africa - Business Wire